Is the calcium antagonist debate having an effect on clinical practice?

Is the calcium antagonist debate having an effect on clinical practice?

Show other versions (1)

The controversies over the long-term safety of calcium antagonists have produced considerable debate in bath the medical and lay press. However, there are no data on whether this debate has influenced routine clinical practice. As most drugs in the Western healthcare systems are prescribed by primar...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Hobbs, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	1997

Eitemau Tebyg

Is the calcium antagonist debate having an effect on clinical practice?
gan: Hobbs, R
Cyhoeddwyd: (1997)

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS
gan: D. V. Nebieridze
Cyhoeddwyd: (2015-12-01)

Risks and benefits of calcium antagonists.
gan: Collins, R, et al.
Cyhoeddwyd: (1995)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE
gan: A. A. Garganeeva
Cyhoeddwyd: (2016-01-01)

The effect of calcium antagonists on the growth of Entamoeba histolytica in vitro
gan: Zahra’a Abdul-Raheem Ahmed, et al.
Cyhoeddwyd: (2010-01-01)

Calcium antagonist effectiveness and tolerability in hypertensive men and women
gan: A. E. Bragina, et al.
Cyhoeddwyd: (2006-08-01)

CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY
gan: R. I. Striuk
Cyhoeddwyd: (2016-01-01)

Challenges in hypotensive therapy: the role of calcium antagonists
gan: E. O. Taratukhin, et al.
Cyhoeddwyd: (2013-04-01)

Calcium antagonists in patients with high cardiovascular risk
gan: A. A. Garganeeva
Cyhoeddwyd: (2009-08-01)

Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
gan: Alderman, M, et al.
Cyhoeddwyd: (1997)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
gan: S. Y. Martsevich
Cyhoeddwyd: (2015-12-01)

Determination of intracellular calcium inhibition effect and cytotoxocity of engineered Bradykinin antagonists.
gan: Tan, Junus Jun Rong.
Cyhoeddwyd: (2013)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS AND THE TREATMENT OF ARTERIAL HYPERTENSION AND OBESITY PATIENTS IN ACCORDANCE WITH THE MODERN CLINICAL GUIDELINES
gan: S. R. Gilyarevskyi, et al.
Cyhoeddwyd: (2014-04-01)

Effect of salmon calcitonin combined with calcium antagonist on blood calcium and phosphorus ion concentration in osteoporosis rats
gan: Jiahao Chen, et al.
Cyhoeddwyd: (2025-02-01)

ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS
gan: Y. A. Karpov, et al.
Cyhoeddwyd: (2016-01-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
gan: I. O. Minushkina
Cyhoeddwyd: (2015-02-01)

PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
gan: E. O. Taratukhin, et al.
Cyhoeddwyd: (2013-04-01)

Why have children? : the ethical debate /
gan: Overall, Christine 1949- author
Cyhoeddwyd: (c201)

Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
gan: M. V. Leonova
Cyhoeddwyd: (1970-01-01)

Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors.
gan: MacMahon, S, et al.
Cyhoeddwyd: (1997)

COMPARATIVE EFFECTIVENESS OF THE COMBINATIONS OF DIURETICS AND DIHYDROPYRIDINE AND NONDIHYDROPYRIDINE CALCIUM ANTAGONISTS IN PATIENTS WITH ARTERIAL HYPERTENSION
gan: B. G. Iskenderov, et al.
Cyhoeddwyd: (2010-12-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES
gan: E. V. Shilova, et al.
Cyhoeddwyd: (2016-01-01)

APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY
gan: S. V. Nedogoda
Cyhoeddwyd: (2016-01-01)

Natural L-type calcium channels antagonists from Chinese medicine
gan: Fangfang Xu, et al.
Cyhoeddwyd: (2024-05-01)

Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
gan: V. B. Mychka, et al.
Cyhoeddwyd: (2008-12-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
gan: E. I. Astashkin, et al.
Cyhoeddwyd: (2013-06-01)

Angiotensin II receptor antagonists – we have moved closer to the patient
gan: L. G. Ratova, et al.
Cyhoeddwyd: (2005-04-01)

METABOLIC EFFECTS OF ALTIAZEM-PP, A PROLONGED CALCIUM ANTAGONIST, IN PATIENTS WITH MILD ARTERIAL HYPERTENSION
gan: I. A. Tvaladze, et al.
Cyhoeddwyd: (2001-08-01)

Does Intravitreal Dopamine Agonist and Antagonist Administration Have Effects on the Brain? An Experimental Study in Rats
gan: Mehmet Nuri Kocak, et al.
Cyhoeddwyd: (2022-02-01)

ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS
gan: T. V. Adasheva, et al.
Cyhoeddwyd: (2016-01-01)

Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
gan: Stefano Speroni, et al.
Cyhoeddwyd: (2025-01-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
gan: V. I. Makolkin
Cyhoeddwyd: (2008-12-01)

Calcium antagonist nifedipine in treating pregnant women with arterial hypertension: pro and contra
gan: N. K. Runikhina, et al.
Cyhoeddwyd: (2007-04-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
gan: L. L. Kirichenko, et al.
Cyhoeddwyd: (2014-02-01)

EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
gan: D. A. Yakhontov, et al.
Cyhoeddwyd: (2016-01-01)

A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
gan: E. I. Emelina, et al.
Cyhoeddwyd: (2015-11-01)

STROKE PREVENTION OPPORTUNITIES FOR CARDIOLOGISTS: COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION (ROLE OF CALCIUM ANTAGONISTS)
gan: E. O. Taratukhin
Cyhoeddwyd: (2013-08-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
gan: O. M. Drapkina, et al.
Cyhoeddwyd: (2020-07-01)

Management of Calcium Channel Antagonist Overdose with Hyperinsulinemia-Euglycemia Therapy: Case Series and Review of the Literature
gan: Shiwan K. Shah, et al.
Cyhoeddwyd: (2012-01-01)

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development
gan: Cipriani, A, et al.
Cyhoeddwyd: (2016)